tiprankstipranks
IQVIA Holdings (CH:QTS)
NYSE:QTS
Switzerland Market

IQVIA Holdings (QTS) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

QTS Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
IQVIA
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QTS Stock 12 Month Forecast

Average Price Target

$181.86
Based on 12 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is $181.86 with a high forecast of $200.47 and a low forecast of $169.07. The average price target represents a change from the last price of .
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
Highest Price Target$200.47Average Price Target$181.86Lowest Price Target$169.07
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
CHF169.07CHF193.22
Buy
Reiterated
07/06/26
Iqvia price target raised to $240 from $210 at HSBCIqvia price target raised to $240 from $210 at HSBC
Robert W. Baird Analyst forecast on CH:QTS
Robert W. Baird
Robert W. Baird
CHF185.17CHF200.47
Buy
Reiterated
07/01/26
Iqvia price target raised to $249 from $230 at BairdIqvia price target raised to $249 from $230 at Baird
Truist Financial Analyst forecast on CH:QTS
Truist Financial
Truist Financial
Buy
Reiterated
06/29/26
Analysts' Top Healthcare Picks: Viridian Therapeutics (VRDN), Ascendis Pharma (ASND)
Barclays Analyst forecast on CH:QTS
Barclays
Barclays
CHF169.07
Buy
Reiterated
06/24/26
IQVIA Holdings (IQV) Receives a Buy from Barclays
Morgan Stanley Analyst forecast on CH:QTS
Morgan Stanley
Morgan Stanley
CHF161.02CHF181.15
Hold
Downgraded
06/18/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BridgeBio Pharma (NASDAQ: BBIO) and Guardant Health (NASDAQ: GH)
Argus Research Analyst forecast on CH:QTS
Argus Research
Argus Research
Buy
Reiterated
05/29/26
Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)
Bank of America Securities Analyst forecast on CH:QTS
Bank of America Securities
Bank of America Securities
CHF197.25
Buy
Reiterated
05/13/26
Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects
BMO Capital Analyst forecast on CH:QTS
BMO Capital
BMO Capital
CHF169.07
Buy
Assigned
05/08/26
IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
Jefferies Analyst forecast on CH:QTS
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF177.12
Buy
Reiterated
05/06/26
Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)
TD Cowen
CHF171.49
Buy
Reiterated
05/05/26
IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
RBC Capital Analyst forecast on CH:QTS
RBC Capital
RBC Capital
CHF177.93
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)
William Blair Analyst forecast on CH:QTS
William Blair
William Blair
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)
Evercore ISI
CHF181.15CHF148.94
Buy
Reiterated
04/08/26
Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI
Citi
CHF161.02
Hold
Assigned
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on CH:QTS
Mizuho Securities
Mizuho Securities
CHF214.16CHF173.1
Buy
Reiterated
02/23/26
Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
CHF169.07CHF193.22
Buy
Reiterated
07/06/26
Iqvia price target raised to $240 from $210 at HSBCIqvia price target raised to $240 from $210 at HSBC
Robert W. Baird Analyst forecast on CH:QTS
Robert W. Baird
Robert W. Baird
CHF185.17CHF200.47
Buy
Reiterated
07/01/26
Iqvia price target raised to $249 from $230 at BairdIqvia price target raised to $249 from $230 at Baird
Truist Financial Analyst forecast on CH:QTS
Truist Financial
Truist Financial
Buy
Reiterated
06/29/26
Analysts' Top Healthcare Picks: Viridian Therapeutics (VRDN), Ascendis Pharma (ASND)
Barclays Analyst forecast on CH:QTS
Barclays
Barclays
CHF169.07
Buy
Reiterated
06/24/26
IQVIA Holdings (IQV) Receives a Buy from Barclays
Morgan Stanley Analyst forecast on CH:QTS
Morgan Stanley
Morgan Stanley
CHF161.02CHF181.15
Hold
Downgraded
06/18/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BridgeBio Pharma (NASDAQ: BBIO) and Guardant Health (NASDAQ: GH)
Argus Research Analyst forecast on CH:QTS
Argus Research
Argus Research
Buy
Reiterated
05/29/26
Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)
Bank of America Securities Analyst forecast on CH:QTS
Bank of America Securities
Bank of America Securities
CHF197.25
Buy
Reiterated
05/13/26
Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects
BMO Capital Analyst forecast on CH:QTS
BMO Capital
BMO Capital
CHF169.07
Buy
Assigned
05/08/26
IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
Jefferies Analyst forecast on CH:QTS
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF177.12
Buy
Reiterated
05/06/26
Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)
TD Cowen
CHF171.49
Buy
Reiterated
05/05/26
IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
RBC Capital Analyst forecast on CH:QTS
RBC Capital
RBC Capital
CHF177.93
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)
William Blair Analyst forecast on CH:QTS
William Blair
William Blair
Buy
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)
Evercore ISI
CHF181.15CHF148.94
Buy
Reiterated
04/08/26
Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI
Citi
CHF161.02
Hold
Assigned
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on CH:QTS
Mizuho Securities
Mizuho Securities
CHF214.16CHF173.1
Buy
Reiterated
02/23/26
Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

3 Months
David WindleyJefferies
Success Rate
21/32 ratings generated profit
66%
Average Return
+2.76%
Copying David Windley's trades and holding each position for 3 Months would result in 65.63% of your transactions generating a profit, with an average return of +2.76% per trade.
1 Year
Success Rate
15/19 ratings generated profit
79%
Average Return
+10.99%
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 78.95% of your transactions generating a profit, with an average return of +10.99% per trade.
2 Years
David WindleyJefferies
Success Rate
24/32 ratings generated profit
75%
Average Return
+7.42%
Copying David Windley's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +7.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QTS Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
23
22
21
18
18
Hold
7
6
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
28
22
20
19
In the current month, QTS has received 18 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. QTS average Analyst price target in the past 3 months is 181.86.
Each month's total comprises the sum of three months' worth of ratings.

QTS Financial Forecast

QTS Earnings Forecast

Next quarter’s earnings estimate for QTS is $2.46 with a range of $2.43 to $2.49. The previous quarter’s EPS was $2.35. QTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.
Next quarter’s earnings estimate for QTS is $2.46 with a range of $2.43 to $2.49. The previous quarter’s EPS was $2.35. QTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.

QTS Sales Forecast

Next quarter’s sales forecast for QTS is $3.48B with a range of $3.45B to $3.51B. The previous quarter’s sales results were $3.36B. QTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.
Next quarter’s sales forecast for QTS is $3.48B with a range of $3.45B to $3.51B. The previous quarter’s sales results were $3.36B. QTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.

QTS Stock Forecast FAQ

What is CH:QTS’s average 12-month price target, according to analysts?
Based on analyst ratings, IQVIA Holdings’s 12-month average price target is 181.86.
    What is CH:QTS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:QTS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is IQVIA Holdings a Buy, Sell or Hold?
        IQVIA Holdings has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
          What is IQVIA Holdings’s share price target?
          The average share price target for IQVIA Holdings is 181.86. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $200.47 ,and the lowest forecast is $169.07. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about IQVIA Holdings?
            IQVIA Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of IQVIA Holdings?
              To buy shares of CH:QTS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.